Dyax Corp. Announces Five HAE Allies? Honorees, Underscoring Critical Role Of Support For Patients With Hereditary Angioedema

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced five HAE Allies honorees chosen as the first to be recognized by the program for their contributions in supporting those with hereditary angioedema (HAE) to live life to the fullest. By drawing from the inspiring stories of individuals nationwide, the HAE Allies program hopes to underscore the value of support for those living with this potentially life-threatening condition, which is characterized by spontaneous episodes of edema, or swelling, in the face, feet, hands, throat and abdomen.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC